Guggenheim Reiterates Buy on Allergan (AGN) Following Updated Guidance

Allergan Announces Updated Second-Half 2015 Continuing Operations Financial Forecast

DUBLIN, Sept. 28, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced its updated second-half 2015 continuing operations financial forecast.  The forecast reflects adjustments for the upcoming expected discontinued operations as a result of the previously announced divestiture of its Global Generics business to Teva Pharmaceuticals. The Company intends to begin reporting its Global Generics business as discontinued operations with its third quarter 2015 results. The transaction with Teva is expected to close in the first quarter of 2016. 

Logo -... More

Allergan Launches Generic Version of INVEGA® (paliperidone)

DUBLIN, Sept. 25, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has launched a generic version of Janssen's INVEGA® (paliperidone extended-release tablets) in the U.S.  Allergan is the first company to receive FDA approval for and launch a generic version of INVEGA®, demonstrating the deep expertise of the Company's global generics R&D, regulatory and supply chain teams.

Logo- http://photos.prnewswire.com/prnh/20150612/222796LOGO

"This launch reinforces Allergan's commitment... More

Aegon Acquires Mercer's US Defined Contribution Record-Keeping Business

THE HAGUE, The Netherlands, September 25, 2015 /PRNewswire/ --

Deal strengthens Transamerica's retirement platform and adds USD 71 billion in assets under administration 

Aegon, through an affiliate of its Transamerica unit, has reached an agreement with Mercer HR Services, LLC to acquire Mercer's US defined contribution administration book of business. Upon completion of the acquisition, the defined contribution business will transition to Transamerica Retirement Solutions, which will become a top ten defined contribution record-keeper based on plan participants and... More